RÉSUMÉ
BACKGROUND: Strongyloides westeri is found in the small intestine of young horses, mainly in foals up to about 16 weeks of age. The main source of infection for foals is through transmammary transmission, and foals can develop acute diarrhoea, weakness, dermatitis and respiratory signs. The epidemiology of S. westeri in Australia is largely unknown. Further, molecular techniques have never been employed for detection of S. westeri in horses. This pilot study aimed to assess the utility of a molecular phylogenetic method for the detection of S. westeri in the faeces of foals. METHODS: Faecal samples were collected from a foal of less than 2 months of age, and eggs of Strongyloides sp. were detected using the modified McMaster technique. DNA was extracted from purified eggs, and a partial fragment of the small subunit of the nuclear ribosomal DNA (18S) was characterised using polymerase chain reaction, DNA sequencing and phylogenetic methods. RESULTS: Microscopic examination of faeces revealed small ellipsoidal eggs typical of Strongyloides sp. The 18S sequence generated by PCR in this study revealed 98.4% identity with that of a reference sequence of S. westeri available from GenBank. Phylogenetic analyses revealed a polyphyletic clustering of S. westeri sequences. CONCLUSION: This is the first study reporting the detection of DNA of Strongyloides sp. in faeces of a foal using a molecular phylogenetic approach targeting the variable region of 18S rDNA. It is anticipated that this study will allow future molecular epidemiological studies on S. westeri in horses.
Sujet(s)
Maladies des chevaux/parasitologie , Phylogenèse , Strongyloides/génétique , Strongyloïdose/épidémiologie , Strongyloïdose/médecine vétérinaire , Facteurs âges , Animaux , Antiparasitaires/usage thérapeutique , Australie/épidémiologie , Sélection , ADN des helminthes/génétique , Fèces/parasitologie , Maladies des chevaux/traitement médicamenteux , Maladies des chevaux/épidémiologie , Equus caballus , Ivermectine/usage thérapeutique , Numération des oeufs de parasites , Projets pilotes , Strongyloides/classification , Strongyloides/effets des médicaments et des substances chimiques , Strongyloides/isolement et purification , Strongyloïdose/traitement médicamenteuxRÉSUMÉ
This research was undertaken to evaluate the nematicidal activity of various concentrations of aqueous tinctures of 80 plant species towards L1-2 of S. papillosus. For the experiment with larvae of S. papillosus, there were used 0.19%, 0.75% and 3.00% aqueous tinctures of plants. Out of 80 tested species, nematicidal activity against L1-2 of S. papillosus was displayed by 20 plants. The greatest activity (LC50 = 0.060-0.069%) towards larvae of S. papillosus was exerted by Teucrium polium, Achillea millefolium, Genista tinctoria and Ulmus laevis. Less expressed nematicidal activity (LC50 = 0.070-0.079%) was recorded for Thalictrum minus, Stachys recta, Falcaria vulgaris, Lavatera thuringiaca. Even lower effect (LC50 = 0.080-0.089%) was shown by aqueous tinctures of Mentha × piperita, Achillea millefolium, Salvia nutans, Eryngium campestre and Cerasus fruticosa. The following plants could be arranged in declining order of effectiveness of nematicidal activity (LC50 = 0.090-0.165%) Malus sylvestris, Tragopogon orientalis, Erigeron annuus, Grindelia squarrosa, Urtica dioica, Daucus carota, Medicago sativa, Carduus acanthoides, Ulmus minor and Hieracium umbellatum. A far weaker effect on the nematodes was displayed by Bromopsis inermis and Tragopogon podolicus. Aqueous tinctures of 60 other studied species of plants exhibited low nematicidal activity in 3.00% aqueous tincture, while in 0.19% and 0.75% aqueous tinctures, no nematicidal activity was seen. The results of the research suggest that in the conditions of natural ecosystems, some species of plants of the Apiaceae, Asteraceae, Fabaceae, Lamiaceae, Malvaceae, Rosaceae, Ulmaceae and Urticaceae families could reduce vitality of free-living L1-2 larvae of S. papillosus.
Sujet(s)
Antihelminthiques antinématodes , Apiaceae , Asteraceae , Malvaceae , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Antihelminthiques antinématodes/pharmacologie , Apiaceae/composition chimique , Asteraceae/composition chimique , Larve/effets des médicaments et des substances chimiques , Malvaceae/composition chimique , Composés phytochimiques/pharmacologieRÉSUMÉ
OBJECTIVES: To evaluate the antibacterial, antifungal and anthelmintic activities of the ethanolic extract (EEMz), fractions (LPFMz and HPFMz) and compounds isolated from the leaves of Manilkara zapota L. P. Royen. METHODS: Extract and fractions were produced by turbolization. LPFMz fraction was analysed by gas chromatography-mass spectrometry. The isolated compounds from HPFMz were purified by flash and preparative chromatographic methods, and chemically characterised by UPLC-ESITOFMS, optical rotation, and one- and two-dimensional 1H and 13C NMR techniques. Anthelmintic against Strongyloides venezuelensis and antimicrobial activities against Candida albicans, Trichophyton rubrum and Staphylococcus aureus were evaluated. KEY FINDINGS: EEMz showed mainly phenolic compounds and pentacyclic triterpenes from Δ12-oleane/Δ12-ursane series. Chlorogenic acid, myricetin-3-O-ß-D-glucopyranoside, mearnsitrin, germanicol and germanicol acetate were reported to M. zapota leaves for the first time in this work. EEMz, HPFMz, LPFMz showed significative activity against C. albicans (16 µg/mL), while isolated flavonoids were active against S. aureus (<32 µg/mL). EEMz, phenolic-rich compounds (F2), and chlorogenic acid were potentially active against S. venezuelensis at 24 h. CONCLUSIONS: M. zapota and its bioactive compound can be eligible such as a potential phytomedicine for the treatment of microbial and strongyloidiasis drug-resistant infections.
Sujet(s)
Anthelminthiques/pharmacologie , Antibactériens/pharmacologie , Antifongiques/pharmacologie , Manilkara/composition chimique , Extraits de plantes/pharmacologie , Animaux , Anthelminthiques/isolement et purification , Antibactériens/isolement et purification , Antifongiques/isolement et purification , Arthrodermataceae/effets des médicaments et des substances chimiques , Candida albicans/effets des médicaments et des substances chimiques , Femelle , Chromatographie gazeuse-spectrométrie de masse , Mâle , Feuilles de plante , Rats , Rat Wistar , Staphylococcus aureus/effets des médicaments et des substances chimiques , Strongyloides/effets des médicaments et des substances chimiquesRÉSUMÉ
Strongyloidiasis is a parasitosis that represents a public health problem, in tropical regions. The present study aimed to investigate the anthelmintic effects of several extracts of Argemone mexicana, as well as its main component berberine (Ber) against the third-stage larvae (L3) of Strongyloides venezuelensis in-vitro experiments. Also, the anti-hemolytic activity of the extract, fractions, and Ber were tested in human erythrocytes. A dose-response anthelminthic bioassay demonstrated Ber as the most effective component, followed by methanolic subfraction (Fr3) and finally the crude extract of A. mexicana (Am) showing LC50 response values of 1.6, 19.5, and 92.1 µg/mL, at 96 h respectively. Also, Am, Fr3, and Ber did not produce significant hemolysis against human erythrocytes (p ≤ 0.05). Am and Fr3 showed erythrocyte protection effect capacity at the membrane level (p ≤ 0.05). Furthermore, Ber was found to have an antioxidant activity of 168.18 µg/mL. According to the results, the Fr3 of A. mexicana, and particularly Ber, exhibited potent in-vitro effects against L3 of S. venezuelensis, without hemolytic activity against human erythrocytes and presented good antioxidant capacity. In conclusion, the extracts of A. mexicana and the main component have activity against S. venezuelensis, nevertheless, further studies are required to elucidate the mechanism of action.
Sujet(s)
Anthelminthiques/pharmacologie , Argemone/composition chimique , Berbérine/pharmacologie , Extraits de plantes/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Anthelminthiques/composition chimique , Anthelminthiques/usage thérapeutique , Berbérine/composition chimique , Berbérine/usage thérapeutique , Dosage biologique , Relation dose-effet des médicaments , Érythrocytes/effets des médicaments et des substances chimiques , Fèces/parasitologie , Hémolyse/effets des médicaments et des substances chimiques , Humains , Larve/effets des médicaments et des substances chimiques , Dose létale 50 , Mâle , Extraits de plantes/composition chimique , Extraits de plantes/usage thérapeutique , Feuilles de plante/composition chimique , Tiges de plante/composition chimique , Rats , Rat Wistar , Strongyloïdose/traitement médicamenteuxRÉSUMÉ
INTRODUCTION: Imported parasitosis, which do not require an invertebrate vector, are extremely dangerous and can lead to the occurrence of disease in currently parasite free areas. In the present study we report a case of multi-parasitic infection in a young immigrant from Ghana to Italy caused by filaria, Schistosoma sp. and Strongyloides sp. CASE PRESENTATION: A 27-year-old Ghanaian man attended the Hospital of Nuoro (Sardinia), Italy, at the end of August 2015, claiming pain to the kidney and hypertensive crisis; the patient presented with dyspnea and epistaxis, chronic itchy skin of the back, shoulders, arms and legs, anuria and high creatinine, metabolic acidosis and hypereosinophilic syndrome. Serological test for parasitic infections were done, and showed a marked positivity for filaria, Schistosoma sp. and Strongyloides sp. The patient started the treatment immediately with two doses per day of Bassado Antibiotic (tetracycline) for twenty days and then with a single dose of 3 mg of ivermectin that was repeated after 3 months. CONCLUSIONS: Immigrant patients from endemic areas who show clinical signs, such as a general itching on the back, shoulders and arms and legs, should have a thorough history in order to make early diagnosis and prevent further complications. Therefore, general practitioners and doctors in Europe and in other parasitosis non-endemic countries, should consider to test for parasites in any immigrant from endemic countries to aid in establishing the final diagnosis and prevent further complications.
Sujet(s)
Co-infection/diagnostic , Maladies transmissibles importées/diagnostic , Maladies transmissibles importées/parasitologie , Émigrants et immigrants , Filarioses/diagnostic , Schistosomiase/diagnostic , Strongyloïdose/diagnostic , Adulte , Animaux , Anthelminthiques/usage thérapeutique , Co-infection/traitement médicamenteux , Co-infection/parasitologie , Filarioses/traitement médicamenteux , Ghana , Humains , Italie , Mâle , Schistosoma/effets des médicaments et des substances chimiques , Strongyloides/effets des médicaments et des substances chimiquesSujet(s)
Diarrhée/parasitologie , Strongyloides/isolement et purification , Strongyloïdose/parasitologie , Animaux , Anticorps antihelminthe/sang , Antihelminthiques antinématodes/usage thérapeutique , Maladie chronique , Diarrhée/diagnostic , Diarrhée/traitement médicamenteux , Humains , Ivermectine/usage thérapeutique , Mâle , Adulte d'âge moyen , Strongyloides/effets des médicaments et des substances chimiques , Strongyloides/immunologie , Strongyloïdose/complications , Strongyloïdose/diagnostic , Strongyloïdose/traitement médicamenteux , Résultat thérapeutiqueRÉSUMÉ
Strongyloidiasis is a human parasitic disease caused by the helminth Strongyloides stercoralis whose treatment is particularly difficult in immunosuppressed patients due to their low responsiveness to conventional therapy. Carica papaya and its isolated compounds benzyl isothiocyanate, carpaine and carpasemine are promising compound for the treatment of Strongyloides infections due to their anthelmintic action. This study aims to examine the in vitro ovicidal and larvicidal activity of C. papaya seed hexane extract against Strongyloides venezuelensis, using egg hatching tests and larval motility tests as efficiency markers. The crude extract at the concentrations of 566 - 0.0566 mg/mL or the control with albendazole (0.025 mg/mL) and negative controls (water and PBS) were incubated with an equal volume of egg suspension (± 50 specimens) followed by counting of the specimens after 48 h. The same extract and dilutions were added to L3 larvae suspensions (±50 specimens) followed by analysis of larvae viability after 24, 48, and 72 h. The extract inhibited egg hatching with high efficiency at concentrations of 56.6 mg/mL (95.74%) and 5.66 mg/mL (92.16%). At the concentrations of 566 mg/mL (100%) and 56.66 mg/mL (97.32%), the extract inhibited larval motility as effectively as ivermectin (0.316 mg/mL; 100%), and more effectively than the other dilutions and the negative controls. The larvicidal effect depended on the extract concentration, but not on the treatment period. Therefore, C. papaya seed hexane extract has anthelmintic potential against S. venezuelensis and is a promising compound for the development of phytotherapies to treat strongyloidiasis.
Sujet(s)
Carica/composition chimique , Larve/effets des médicaments et des substances chimiques , Ovule/effets des médicaments et des substances chimiques , Extraits de plantes/pharmacologie , Graines/composition chimique , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Tests de sensibilité parasitaireRÉSUMÉ
BACKGROUND: Phospholipases A2 (PLA2) from snake venoms have a broad potential as pharmacological tools on medicine. In this context, strongyloidiasis is a neglected parasitic disease caused by helminths of the genus Strongyloides. Currently, ivermectin is the drug of choice for treatment, however, besides its notable toxicity, therapeutic failures and cases of drug resistance have been reported. BnSP-6, from Bothorps pauloensis snake venom, is a PLA2 with depth biochemical characterization, reporting effects against tumor cells and bacteria. OBJECTIVE: The aim of this study is to demonstrate for the first time the action of the PLA2 on Strongyloides venezuelensis. METHODS: After 72 hours of treatment with BnSP-6 mortality of the infective larvae was assessed by motility assay. Cell and parasite viability was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Furthermore, autophagic vacuoles were labeled with Monodansylcadaverine (MDC) and nuclei of apoptotic cells were labeled with Propidium Iodide (PI). Tissue degeneration of the parasite was highlighted by Transmission Electron Microscopy (TEM). RESULTS: The mortality index demonstrated that BnSP-6 abolishes the motility of the parasite. In addition, the MTT assay attested the cytotoxicity of BnSP-6 at lower concentrations when compared with ivermectin, while autophagic and apoptosis processes were confirmed. Moreover, the anthelmintic effect was demonstrated by tissue degeneration observed by TEM. Furthermore, we report that BnSP-6 showed low cytotoxicity on human intestinal cells (Caco-2). CONCLUSION: Altogether, our results shed light on the potential of BNSP-6 as an anthelmintic agent, which can lead to further investigations as a tool for pharmaceutical discoveries.
Sujet(s)
Anthelminthiques/pharmacologie , Venins de crotalidé/pharmacologie , Phospholipases A2/pharmacologie , Venins de serpent/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Anthelminthiques/composition chimique , Anthelminthiques/isolement et purification , Bothrops , Cellules Caco-2 , Mort cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Venins de crotalidé/composition chimique , Venins de crotalidé/isolement et purification , Relation dose-effet des médicaments , Femelle , Humains , Phospholipases A2/composition chimique , Phospholipases A2/isolement et purification , Rats , Rat Wistar , Venins de serpent/composition chimique , Venins de serpent/isolement et purification , Strongyloides/parasitologie , Relation structure-activitéRÉSUMÉ
New therapeutic approaches are necessary to control strongyloidiasis due to the side effects of, and resistance to, currently available drugs thiabendazole, albendazole, and ivermectin. This study examined the anthelmintic properties of extracts and isolated compounds from Siparuna guianensis against Strongyloides venezuelensis eggs and larvae, using the egg hatching test (EHT) and larval motility test (LMT). Albendazole (0.025 mg/ml) and ivermectin (0.316 mg/ml) were used as the positive controls for the EHT and LMT assays, respectively. Strongyloides venezuelensis eggs or larvae (±50 specimens) were treated with ethanol extract (0.05-1.0 mg/ml), ethyl acetate and aqueous fractions (0.05-0.8 mg/ml), essential oil (0.2-1.0 mg/ml) and α-bisabolol (0.2-1.0 mg/ml) from S. guianensis, and analysed by optical microscopy after 48 h (EHT), or after 24, 48 and 72 h (LMT). All the tested compounds exhibited ovicidal activity equivalent to the positive control and changed the morphology of the eggs. The S. guianensis ethanol extract and aqueous fraction were as effective as the positive control. Phytochemical analysis of the ethanol extract and fractions revealed the presence of phenolic compounds, tannins and flavonoids. Therefore, S. guianensis is effective against S. venezuelensis eggs and larvae in vitro, and can be considered as a potential alternative treatment for strongyloidiasis.
Sujet(s)
Anthelminthiques/pharmacologie , Huile essentielle/pharmacologie , Extraits de plantes/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Tracheobionta/composition chimique , Animaux , Anthelminthiques/composition chimique , Larve/effets des médicaments et des substances chimiques , Sesquiterpènes monocycliques/composition chimique , Sesquiterpènes monocycliques/pharmacologie , Huile essentielle/composition chimique , Ovule/effets des médicaments et des substances chimiques , Extraits de plantes/composition chimiqueRÉSUMÉ
Parasite control in foals is complicated by the concurrent presence of biologically diverse parasites with differing levels of anthelmintic resistance. Several combination anthelmintic products are available for use in horses, but information on their efficacies against important equine parasites is scarce. Two trials were performed in New Zealand during 2008 and 2011 on four different farms with substantially different anthelmintic treatment histories. The first trial evaluated the efficacy of an ivermectin/praziquantel/oxibendazole combination, a single active oxibendazole, and a single-active macrocyclic lactone (ML) in 49 foals located on three farms. The second trial evaluated two combination anthelmintic products and three single-active ML products and enrolled a total of 110 foals on three farms. Foals in the second trial were allocated to one of six anthelmintic treatment groups; oxfendazole/pyrantel embonate, pyrantel embonate/ivermectin/praziquantel, ivermectin/praziquantel, abamectin/praziquantel, moxidectin/praziquantel, and a placebo-treated control. In both trials, foals were monitored monthly prior to treatment, and fecal egg counts (FECs) of Parascaris spp., strongylid, and Strongyloides westeri were determined. A "rolling enrolment" process was implemented whereby foals were systematically allocated to a treatment group and treated with the corresponding anthelmintic following the first appearance of Parascaris spp. eggs in the faeces. A generalised linear model was used to evaluate the effect of farm and treatment on Day14 FEC (ln) for each parasite. Three different FECR calculation methods were employed as follows; i) FECR(T) pre and post treatment ii) FECR (C) in the treated group compared with control, and iii) FECR (P) pre- and post- treatment in the treated and control groups. Across both trials, treatment with ML single active products failed to achieve >95% reduction in Parascaris spp. FEC on two of three farms. The pyrantel embonate/oxfendazole and ivermectin/ praziquantel/oxibendazole combinations demonstrated full efficacy against Parascaris spp. This is in contrast to the anti-strongylid efficacies determined, where the pyrantel embonate/oxfendazole combination and single active oxibendazole had reduced efficacy on one farm, while the macrocyclic lactones generally had good efficacy. Strongyloides egg counts were sporadic in both trials, and allowed limited insight into anthelmintic efficacy. The study illustrated the importance of keeping an untreated or placebo-treated control group in studies evaluating anti-Parascaris efficacy and it demonstrated the utility of a rolling enrolment procedure, where foals are enrolled over the course of a defined period of time. Furthermore, the study demonstrated the value of a farm specific FECR monitoring programme and the complexity of parasite control in foals, where combination anthelmintic products can be employed to target multiple species of parasites.
Sujet(s)
Anthelminthiques/usage thérapeutique , Infections à Ascaridida/médecine vétérinaire , Maladies des chevaux/traitement médicamenteux , Equus caballus/parasitologie , Facteurs âges , Animaux , Infections à Ascaridida/traitement médicamenteux , Ascaridoidea/effets des médicaments et des substances chimiques , Résistance aux substances , Association de médicaments , Fermes , Fèces/parasitologie , Maladies des chevaux/parasitologie , Ivermectine/analogues et dérivés , Ivermectine/usage thérapeutique , Macrolides/usage thérapeutique , Nouvelle-Zélande , Numération des oeufs de parasites , Strongyloides/effets des médicaments et des substances chimiquesRÉSUMÉ
We aimed to evaluate the effects of ivermectin treatment on gastrointestinal morphology and function after Strongyloides venezuelensis infection. Male rats composed Control (C), Parasitized (Sv), Ivermectin (IVM) and Parasitized and treated with Ivermectin (Sv/IVM) groups. IVM and Sv/IVM groups were subdivided according to IVM: single dose of 200 µg/kg (IVM1 and Sv/IVM1) or three repeated doses of 200 µg/kg at 24 h intervals (IVM3 and Sv/IVM3). First dose of IVM was administered after peak of infection. Eggs per gram (EPG), mean gastric emptying time (MGET), mean cecum arrival time (MCAT) and mean small intestinal transit time (MSITT) were evaluated. Measurements were performed before drug and at peak of infection, first day post peak of infection and 30 days post infection. Same time intervals were simulated for uninfected animals. Number of recovered worms and intestinal morphometry were also rated. Data were analyzed by ANOVA and correlated by Dunnett and Pearson (p < 0.05). Sv/IVM1 and Sv/IVM3 showed reduction of EPG and worms, although only group SV/IVM3 eradicate them. Hastened gastric emptying and slowed intestinal transit provoked by S. venezuelensis infection can be reverted by a single administration of IVM after peak of infection, even without total parasite elimination. Although three consecutive doses of IVM were more efficient to eradicate the parasite, drug administration impaired gastrointestinal function and morphology. IVM alone affected gastrointestinal parameters in uninfected animals for prolonged periods, especially in high doses. In control, there were strong negative correlations between MSITT and muscle layers. Strongyloides venezuelensis infection abolishes such correlations. Longitudinal muscle was thinner in IVM3 and Sv/IVM3 groups and circular thicker in Sv group. Revisiting the action of traditional drugs broadens knowledge in the parasite-host interface and may result in the development of more accurate therapeutic strategies.
Sujet(s)
Antiparasitaires/pharmacologie , Intestin grêle/effets des médicaments et des substances chimiques , Ivermectine/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Strongyloïdose/traitement médicamenteux , Strongyloïdose/physiopathologie , Animaux , Modèles animaux de maladie humaine , Fèces/parasitologie , Transit gastrointestinal/physiologie , Intestin grêle/parasitologie , Mâle , Numération des oeufs de parasites , Rats , Rat Wistar/parasitologie , Strongyloides/physiologie , Strongyloïdose/parasitologieRÉSUMÉ
Alkylphospholipid analogs were initially developed as anticancer agents and were later found to antiparasitic activity. Miltefosine is the prototype alkylphosphocholine and is the first oral treatment against visceral leishmaniasis. Here we investigated the effects of miltefosine and two ring-substituted alkylphosphocholine derivatives, TCAN26 and TC70, on the viability, morphology, and ultrastructure of the life stages of Caenorhabditis elegans and infective larvae of the parasite Strongyloides venezuelensis. Miltefosine displayed activity against C. elegans adults at low concentrations and was more effective than TCAN26 and TC70. Miltefosine inhibited the hatching of eggs, leading to embryonic lethality, and showed larvicidal activity against C. elegans and S. venezuelensis larvae after 24â¯h. Mitelfosine also induced alterations in the reproductive system of hermaphrodites, causing vulvar prolapse and general effects in the body wall. Electron microscopy analysis showed that miltefosine induced selective embryonic lethality, leading to cell death. Our results suggest that alkylphospholipid analogs are a potential new alternative for anti-nematode chemotherapy.
Sujet(s)
Antihelminthiques antinématodes/pharmacologie , Caenorhabditis elegans/effets des médicaments et des substances chimiques , Phospholipides/pharmacologie , Phosphoryl-choline/analogues et dérivés , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Antihelminthiques antinématodes/composition chimique , Caenorhabditis elegans/embryologie , Caenorhabditis elegans/ultrastructure , Fèces/parasitologie , Larve/effets des médicaments et des substances chimiques , Mâle , Microscopie électronique à balayage , Microscopie électronique à transmission , Phospholipides/composition chimique , Phosphoryl-choline/composition chimique , Phosphoryl-choline/pharmacologie , Rats , Rat Wistar , Strongyloides/ultrastructureSujet(s)
Antihelminthiques antinématodes/usage thérapeutique , Antihelminthiques antiplathelminthes/usage thérapeutique , Sélection de donneurs/méthodes , Transplantation d'organe/méthodes , Schistosoma/effets des médicaments et des substances chimiques , Schistosomiase/traitement médicamenteux , Strongyloides/effets des médicaments et des substances chimiques , Strongyloïdose/traitement médicamenteux , Donneurs de tissus , Receveurs de transplantation , Animaux , Antihelminthiques antinématodes/effets indésirables , Antihelminthiques antiplathelminthes/effets indésirables , Sélection de donneurs/normes , Interactions hôte-parasite , Humains , Sujet immunodéprimé , Immunosuppresseurs/effets indésirables , Transplantation d'organe/effets indésirables , Transplantation d'organe/normes , Guides de bonnes pratiques cliniques comme sujet , Appréciation des risques , Facteurs de risque , Schistosoma/isolement et purification , Schistosoma/pathogénicité , Schistosomiase/diagnostic , Schistosomiase/parasitologie , Schistosomiase/transmission , Strongyloides/isolement et purification , Strongyloides/pathogénicité , Strongyloïdose/diagnostic , Strongyloïdose/parasitologie , Strongyloïdose/transmission , Résultat thérapeutiqueRÉSUMÉ
Routine faecal examination of a herd of weaned male goats revealed heavy infections with gastrointestinal strongyles (GIS) and Strongyloides sp. Moxidectin (routinely dosed at 0.3â¯mg·kg-1, i.e., 1.5 times the sheep dose), although fully effective against GIS, failed to control Strongyloides sp., with an estimated faecal egg count reduction (FECR) of only 55.5%. In addition, levamisole (11.25â¯mg·kg-1) and ivermectin (0.3â¯mg·kg-1) also failed to control Strongyloides sp., with FECRs of 1.4% and 53.5%, respectively. On the other hand, albendazole (7.5â¯mg·kg-1) and netobimin (11.25â¯mg·kg-1 and 22.5â¯mg·kg-1) reduced by 96.3-99.9% the Strongyloides sp. faecal egg counts according to dose and remained effective, although, in the past, this drug family has been used extensively on the same farm and was no longer effective against GIS. Albendazole or netobimin at 3 times the dose for sheep may be effective for Strongyloides sp. control in case of severe infection.
Sujet(s)
Anthelminthiques/usage thérapeutique , Épidémies de maladies/médecine vétérinaire , Maladies des chèvres/traitement médicamenteux , Strongyloides/effets des médicaments et des substances chimiques , Strongyloïdose/médecine vétérinaire , Facteurs âges , Albendazole/usage thérapeutique , Animaux , Anthelminthiques/administration et posologie , Résistance aux substances , Fèces/parasitologie , Maladies des chèvres/parasitologie , Capra/parasitologie , Guadeloupe/épidémiologie , Ivermectine/usage thérapeutique , Lévamisole/usage thérapeutique , Macrolides/usage thérapeutique , Mâle , Numération des oeufs de parasites/médecine vétérinaire , Strongyloïdose/épidémiologie , Résultat thérapeutique , Climat tropicalRÉSUMÉ
Latex from Carica papaya is rich in bioactive compounds, especially papain, which may help to control parasitic diseases. This study evaluated the efficacy of latex from C. papaya and purified papain against Strongyloides venezuelensis. The Egg Hatching Test (EHT) and the Larval Motility Test (LMT) using fresh and frozen latex (250mg/mL), lyophilized latex (34mg/mL), and purified papain (2.8 mg/mL) were performed. Albendazole (0.025 mg/mL) and ivermectin (316 ppm) were used as positive controls. EHT and LMT were carried out through the incubation of each solution with S. venezuelensis eggs or larvae (± 100 specimens), and results were analyzed after 48h (EHT) or 24, 48, and 72h (LMT). EHT showed that latex preparations at higher concentrations (1:10 to 1:100) resulted in partial or complete destruction of eggs and larvae inside the eggs. The result from the 1:1,000 dilution was similar to the positive control. LMT showed effectiveness in all the tested dilutions compared to negative controls. Purified papain showed a dose-dependent response in the EHT. Purified papain (2.8 mg/ mL) showed similar results to lyophilized latex at 1:1,000 in the EHT. Latex and purified papain from C. papaya were effective against S. venezuelensis eggs and larvae in vitro, suggesting their potential use as an alternative treatment for strongyloidiasis.
Sujet(s)
Carica/composition chimique , Latex/pharmacologie , Papaïne/pharmacologie , Extraits de plantes/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Relation dose-effet des médicaments , Larve/effets des médicaments et des substances chimiques , Latex/isolement et purification , Ovule/effets des médicaments et des substances chimiques , Papaïne/isolement et purification , Tests de sensibilité parasitaireRÉSUMÉ
ABSTRACT Latex from Carica papaya is rich in bioactive compounds, especially papain, which may help to control parasitic diseases. This study evaluated the efficacy of latex from C. papaya and purified papain against Strongyloides venezuelensis. The Egg Hatching Test (EHT) and the Larval Motility Test (LMT) using fresh and frozen latex (250mg/mL), lyophilized latex (34mg/mL), and purified papain (2.8 mg/mL) were performed. Albendazole (0.025 mg/mL) and ivermectin (316 ppm) were used as positive controls. EHT and LMT were carried out through the incubation of each solution with S. venezuelensis eggs or larvae (± 100 specimens), and results were analyzed after 48h (EHT) or 24, 48, and 72h (LMT). EHT showed that latex preparations at higher concentrations (1:10 to 1:100) resulted in partial or complete destruction of eggs and larvae inside the eggs. The result from the 1:1,000 dilution was similar to the positive control. LMT showed effectiveness in all the tested dilutions compared to negative controls. Purified papain showed a dose-dependent response in the EHT. Purified papain (2.8 mg/ mL) showed similar results to lyophilized latex at 1:1,000 in the EHT. Latex and purified papain from C. papaya were effective against S. venezuelensis eggs and larvae in vitro, suggesting their potential use as an alternative treatment for strongyloidiasis.
Sujet(s)
Animaux , Carica/composition chimique , Latex/pharmacologie , Papaïne/pharmacologie , Extraits de plantes/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Larve/effets des médicaments et des substances chimiques , Latex/isolement et purification , Ovule/effets des médicaments et des substances chimiques , Papaïne/isolement et purification , Tests de sensibilité parasitaireRÉSUMÉ
Strongyloidiasis is widely distributed in the tropical and subtropical areas. Ivermectin is the drug of choice for the treatment. However, the concerns about relying treatment on a single drug make identification of new molecules a priority. Alkylphospholipid analogues, including edelfosine, are a group of synthetic compounds that have shown activity against some parasites. The objective was to assess the in vitro and in vivo activity of edelfosine, miltefosine, perifosine against Strongyloides venezuelensis. Moreover, apoptosis-like mechanism in larvae after treatment was studied. Edelfosine displayed the highest activity and the best selectivity index (LD50=49.6 ± 5.4µM, SI=1.1) compared to miltefosine or perifosine. Third stage larvae after culture with edelfosine were not able to develop an infection in mice. Treatment of mice with edelfosine showed reduction of 47% in parasitic females allocated in the gut. Moreover, DNA fragmentation was observed by TUNEL staining in larvae treated with edelfosine. These results suggest that edelfosine could be an effective drug against strongyloidiasis, probably through induction of apoptosis-like cell death.
Sujet(s)
Antinéoplasiques/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Éther-phospholipides/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Animaux , Relation dose-effet des médicaments , Femelle , Larve/effets des médicaments et des substances chimiques , Souris , Phosphoryl-choline/analogues et dérivés , Phosphoryl-choline/pharmacologie , Strongyloïdose/parasitologieRÉSUMÉ
BACKGROUND: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. METHODS: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 µM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. RESULTS: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 µM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). CONCLUSIONS: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis.
Sujet(s)
Aminoalcools/pharmacologie , Anthelminthiques/pharmacologie , Diamines/pharmacologie , Strongyloides/effets des médicaments et des substances chimiques , Strongyloïdose/traitement médicamenteux , Aminoalcools/composition chimique , Animaux , Anthelminthiques/composition chimique , Diamines/composition chimique , Mâle , Souris , Structure moléculaire , Rats , Strongyloïdose/parasitologie , Relation structure-activitéRÉSUMÉ
We examined the in vitro and in vivo efficacy of plant cysteine proteinases (CPs) derived from pineapple (Ananas comosus) and kiwi fruit (Actinidia deliciosa), and compared their efficacy as anthelmintics to the known effects of CPs from the latex of papaya (Carica papaya) against the rodent intestinal nematode, Heligmosomoides bakeri. Both fruit bromelain and stem bromelain had significant in vitro detrimental effects on H. bakeri but in comparison, actinidain from kiwi fruit had very little effect. However, in vivo trials indicated far less efficacy of stem bromelain and fruit bromelain than that expected from the in vitro experiments (24.5% and 22.4% reduction in worm burdens, respectively) against H. bakeri. Scanning electron microscopy revealed signs of cuticular damage on worms incubated in fruit bromelain, stem bromelain and actinidain, but this was far less extensive than on those incubated in papaya latex supernatant. We conclude that, on the basis of presently available data, CPs derived from pineapples and kiwi fruits are not suitable for development as novel anthelmintics for intestinal nematode infections.
Sujet(s)
Actinidia/composition chimique , Ananas/composition chimique , Anthelminthiques/pharmacologie , Carica/composition chimique , Cysteine proteases/pharmacologie , Intestins/parasitologie , Extraits de plantes/pharmacologie , Strongyloïdose/parasitologie , Animaux , Anthelminthiques/isolement et purification , Cysteine proteases/isolement et purification , Femelle , Fruit/composition chimique , Humains , Mâle , Souris de lignée C3H , Extraits de plantes/isolement et purification , Strongyloides/effets des médicaments et des substances chimiquesRÉSUMÉ
INTRODUCTION: We compared feces culturing in charcoal or vermiculite to obtain Strongyloides venezuelensis larvae. METHODS: Feces (5 g) from infected rats was mixed with vermiculite (10 g) or coal (10 g) in plastic cups and incubated at 28°C for 48 h. Larvae were recovered using Baermann-Moraes method. RESULTS: Significantly higher number of positive larval cultures were recovered from vermiculite than from charcoal (15/17 and 4/17, respectively; p < 0.001; 990.6 ± 307.5 and 215 ± 78.1 larvae, p = 0.027). CONCLUSIONS: Vermiculite yields more larvae and provides cleaner pellets, improving larvae identification and facilitating their use for other purposes.